Options Trading News

May 14, 2012  Mon 2:47 AM CT

One investor is using options to manage a trade in NxStage Medical.

Our tracking systems detected the sale of 3,300 December 15 puts for about $1.52 against no previous open interest. He or she is now obligated to buy shares for $15 if they drop to that level.

The benefit of the strategy is that if the stock never goes that low, the trader simply keeps the premium and the puts will expire worthless. Below $15, the trader will be assigned stock, but the effective entry price would be $13.48. That was major consolidation range in 2007 and mid-2010, so the shares might draw buyers there again.

Selling the puts established that entry price now eliminated the need to time the purchase. (See our Education section for more on how options can be used to manage such trades.)

NXTM fell 2.54 percent to $15.34 on Friday. It rallied about 400 percent between mid-2009 and early 2011 but has been drifting lower since. The company's devices are used for treating patients with conditions such as kidney failure.

The put sale pushed total option volume in the stock to more than 100 times average levels.
Share this article with your friends

Invest Like a Monster - San Antonio: October 9-10

Premium Services

Archived Webinar

Education & Strategy

Options Academy: More on the Covered Call Strategy

Last week, we talked about the Covered Call and the misconceptions that surround it. We spoke about how an investor must realize that the Covered Call is actually a premium collection strategy and not so much a directional one. If an investor can grasp this idea, the investor stands to do a heck of a lot better in the strategy than they currently do.

View more education articles »